-
These studies support inclusion of beef in heart-healthy diets.
-
This retrospective study of all non-psychiatric patients admitted to an academic medical center found that although those placed in contact isolation from the time of admission had no increased risk for delirium, patients moved into isolation after admission were twice as likely to develop delirium during the hospital stay.
-
Results of this year-long intervention trial suggest that an ethanolic extract of curcumin could, together with appropriate dietary and lifestyle changes, play a role in slowing the progression from prediabetes to type 2 diabetes.
-
In this non-inferiority clinical trial, 1-year prophylaxis with an oral lactobacilli probiotic combination proved less effective than trimethoprim-sulfamethoxazole for preventing recurrence of urinary tract infections in postmenopausal women. However, although women in the antibiotic group had a dramatic increase in antibiotic resistance, there was no increase noted in the probiotic group.
-
-
-
The consumption of fish, supplementation with fish oil, and their effects on cardiovascular and pain conditions are common headline-makers in the mainstream media as well as this publication. A more recent line of inquiry involves the effects of omega-3 fatty acids on tumorigenesis, cancer prevalence, and mortality.
-
Prostate cancer is the most commonly diagnosed non-dermatologic cancer and the second leading cause of cancer-related death in U.S. men.1 Its etiology and predisposing factors are inadequately characterized, but probably include some combination of older age, north American and northern European residence (perhaps a diet-related issue), African American race, and genetic similarities within families.
-
-
THE FDA HAS APPROVED A SECOND WEIGHT-LOSS DRUG WITHIN the last month. This product is a combination of phentermine, an anorectic, and the antiepileptic topiramate. Phentermine/topiramate (PHEN/TPM) is manufactured by Catalent Pharma Solutions and marketed by Vivus Inc. as Qsymia.